vyvanse glp 1 Medication for binge eating: How to treat binge eating disorder? What are the potential interactions

The refund is not a full refund - the 25% doctor consultation fee is retained

Fridays Features and Benefits Fridays goes beyond just prescribing medications by offering a range of support services

Results provide context for dosing and outcome expectations

Cardiovascular Outcomes Liraglutide (LEADER trial): 13% reduction in major adverse cardiovascular events (MACE) in patients with Type 2 diabetes and high cardiovascular risk Statistically significant cardiovascular protection Semaglutide (SELECT trial): 20% reduction in MACE in patients with obesity and established cardiovascular disease Studied specifically for cardiovascular outcomes in obesity (not just diabetes) Both medications provide cardiovascular protection, but semaglutides evidence is more recent, more robust, and specifically applicable to patients with obesity regardless of diabetes status